Adicet Bio, Inc.
ACET · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $24,990 | $9,730 |
| % Growth | – | -100% | 156.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $24,990 | $9,730 |
| % Margin | – | – | 100% | 100% |
| R&D Expenses | $99,323 | $106,043 | $71,246 | $48,943 |
| G&A Expenses | $28,292 | $26,533 | $26,295 | $22,220 |
| SG&A Expenses | $28,292 | $26,533 | $26,295 | $22,220 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $19,462 | $0 | $0 |
| Operating Expenses | $127,615 | $152,038 | $97,541 | $71,163 |
| Operating Income | -$127,615 | -$152,038 | -$72,551 | -$61,433 |
| % Margin | – | – | -290.3% | -631.4% |
| Other Income/Exp. Net | $10,493 | $9,380 | $2,761 | -$691 |
| Pre-Tax Income | -$117,122 | -$142,658 | -$69,790 | -$62,124 |
| Tax Expense | $0 | $0 | $0 | -$125 |
| Net Income | -$117,122 | -$142,658 | -$69,790 | -$61,999 |
| % Margin | – | – | -279.3% | -637.2% |
| EPS | -1.33 | -3.31 | -1.7 | -2 |
| % Growth | 59.8% | -94.7% | 15% | – |
| EPS Diluted | -1.33 | -3.31 | -1.7 | -2 |
| Weighted Avg Shares Out | 87,866 | 43,042 | 41,080 | 30,952 |
| Weighted Avg Shares Out Dil | 87,866 | 43,042 | 41,080 | 30,952 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,714 | $9,953 | $3,760 | $91 |
| Interest Expense | $4 | $0 | $80 | $176 |
| Depreciation & Amortization | $6,468 | $6,098 | $5,009 | $1,538 |
| EBITDA | -$110,650 | -$136,535 | -$64,701 | -$60,410 |
| % Margin | – | – | -258.9% | -620.9% |